Arformoterol tartrate polymorph A and D

ARFORMOTEROL, FORMOTEROL, GLYCOPYRROLATE,  INDACATEROL, OLODATEROL SALMETEROL, TIOTROPIUM, UMECLIDINIUM and VILANTEROL

More than twenty years’ experience in micronisation.  Inke is able to provide solutions for early market entry opportunities or for products requiring in-depth knowledge of micronisation techniques.
Our experience in in-house micronisation technology at Inke means we can provide:

...

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Otilonium bromide for treating irritable bowel syndrome

EU DMF

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Tafamidis for Trnsthyretin amyloidosis

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aclidinium. Indication: COPD treatment

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aprepitant. Indication: Emesis

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Asenapine. Indications: Schizophrenia and acute mania

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Carvedilol. Indications: hypertension, angina and heart failure


JP DMF available

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Clevidipine. Indication: Hypertension

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Desloratadine. Indication: Allergy

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Eletriptan HBr. Indications: Migraine

JP DMF available

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Enalapril maleate. Indication: Hypertension

CEP and KR DMF available

Complete overview of Inke’s API product portfolio and development pipeline, covering Inhalation, CNS, Ophthalmic HPAPIs and Specialty APIs. The document includes product indications, micronisation availability, regulatory status (CEPs and DMFs), and development stage information for pipeline products.